Skip to main content
Multiple Myeloma
GEM-POMCIDEX Study: Treatment of Patients with RRMM Using Pomalidomide, Cyclophosphamide, and Dexamethasone (POMCIDEX)
Read More
Multiple Myeloma
Assessment of Options for Patients with RRMM with Triple-Class Exposure: Literature Review Indicates Urgent Need for New Treatments
Read More
Multiple Myeloma
Definition and Prediction of Unsustained Complete Remission in Patients with Transplant-Eligible MM
Read More
Multiple Myeloma
MRD Status Comparison by 3 Techniques in Patients with Newly Diagnosed Transplant-Eligible MM
Read More
Lung Cancer
Patients with BRAF V600E–Mutant NSCLC Show Improved Overall Survival with Dabrafenib + Trametinib Combination
Read More
Lung Cancer
GEOMETRY Mono-1 Results: Capmatinib for the Treatment of MET Exon 14–Mutated NSCLC
Read More
Lung Cancer
Ramucirumab plus Erlotinib in the Treatment of Patients with NSCLC with EGFR Exon 19 or Exon 21 Mutations
Read More
Lung Cancer
First-Line Treatment with Lorlatinib Improves Outcomes Over Crizotinib in Patients with ALK-Positive NSCLC
Read More
Lung Cancer
Pralsetinib and Selpercatinib Evaluated as Treatment for Patients with RET Gene Fusion–Positive NSCLC
Read More
Lung Cancer
Trastuzumab Deruxtecan in Patients with HER2-Mutated Advanced NSCLC
Read More
Page 101 of 199
Results 1001 - 1010 of 1986